Search
for
Sort by
Research 20
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Study on the mechanism that SNPs related to sex hormone metabolism regulate the imbalance of sex hormones and lead to BPH in rats
- Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity
- (192) Evaluating Effect of hCG and hCG+rFSH Therapy on Ejaculation Disorders in Middle-Aged Men: A Case Study
- Onychomatricoma with classic features: Case report and review of the literature
- Emerging medication for the treatment of male hypogonadism
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- Pattern Alopecia during Hormonal Anticancer Therapy in Patients with Breast Cancer
- Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- Drug safety evaluation of exemestane
- Steroid Hormones of Reproduction and Sexual Development
- Original article / Article original Counterfeit drugs and pharmaceutical preparations seized from the black market among bodybuilders Médicaments de contrefaçon et préparations pharmaceutiques saisis sur le marché noir parmi les bodybuilders
- Hormone Blocking Anticancer Drugs
- Is dehydroepiandrosterone a hormone?
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Bee pollen and honey for the alleviation of hot flushes and other menopausal symptoms in breast cancer patients
- Local synthesis and effect of sex steroids in human skin and the hair follicle and hormonal effects on the wound healing response
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer